Financing, Equity Capital Markets

Fulgent Genetics, Inc.

11/19
|
$30.0 Million
Piper Sandler served as left bookrunner for Fulgent Genetics, Inc. on a confidentially marketed follow-on offering
Sub-Type
CMFO
Sub-Sector
Life Sciences Tools & Diagnostics